Impressum Bookmark Kontakt Sitemap

Solide Tumoren - Leber, Galle, Pankreas - Leberzellkarzinome -
Weiterführende Informationen

Leberzellkarzinome

Leitlinien

 

Deutsche S3-Leitlinie in Erstellung.

 

Leitlinie der AASL: Bruix J, Sherman M: Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36

 

http://www3.interscience.wiley.com/cgi-bin/fulltext/112136248/PDFSTART

 

Studien

 

www.studien.de (DKG), www.eortc.be (EORTC), www.clinicaltrials.gov (NIH/USA)

 

Literatur

 

  1. Llovet JM et al: Systematic Review of Randomized Trials for Unresectable Hepatocellular Carcinoma: Chemoembolization Improves Survival. Hepatology 2003; 37: 429–442
  2. El-Serag HB et al: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132: 2557–76
  3. Lo C-M et al: Randomized Controlled Trial of Transarterial Lipiodol Chemoembolization for Unresectable Hepatocellular Carcinoma. Hepatology 2002; 35: 1164–1171
  4. Burrhoughs A: Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol 2004; 5: 409–18 (Übersicht)
  5. Koniaris LG: Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg. 2011; 254: 527–38
  6. Lerut J: Hepatic transplantation for hepatocellular carcinoma: state of the art. J Chir 2007; 144: 105–10
  7. Nathan H et al: Predictors of survival after resection of early hepatocellular carcinom. Ann Surg 2009; 249: 799–805
  8. Schwartz M et al: Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007; 4: 424–32
  9. Tiong L et al: Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98: 1210–24
  10. Ueno S et al: Surgical resection versus radiofrequency ablation for small hepatocellular carcinoma within the Milan criteria. J Hepatobiliary Pancreat Surg 2009; 16: 359–66
  11. Wands JR: Prevention of hepatocellular carcinoma. N Engl J Med 2004; 351: 1567–70
  12. Wang X: Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: a meta-analysis of randomized trials. Hepatogastroenterology.2011; 58: 869–74